RPA1 |
RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
1.59E4 |
Evidence |
O
|
MCM5 |
MCM5, CDC46: DNA replication licensing factor MCM5 |
MCM6 |
MCM6: DNA replication licensing factor MCM6 |
1.59E4 |
Evidence |
O
|
PSMA2 |
PSMA2, PSC3: Proteasome subunit alpha type-2 |
PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
1.59E4 |
Evidence |
O
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
1.46E4 |
Evidence |
O
|
INHBB |
INHBB: Inhibin beta B chain precursor |
ACVR2A |
ACVR2A, ACVR2: Activin receptor type-2A precursor |
1.43E4 |
Evidence |
O
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
GRAP |
GRAP: GRB2-related adapter protein |
1.41E4 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
RFC3 |
RFC3: Replication factor C subunit 3 |
1.25E4 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
RFC4 |
RFC4: Replication factor C subunit 4 |
1.25E4 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
RFC5 |
RFC5: Replication factor C subunit 5 |
1.25E4 |
Evidence |
O
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
1.20E4 |
Evidence |
O
|
PSMC1 |
PSMC1: 26S protease regulatory subunit 4 |
PSMD2 |
PSMD2, TRAP2: 26S proteasome non-ATPase regulatory subunit 2 |
1.17E4 |
Evidence |
O
|
F2 |
F2: Prothrombin precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.16E4 |
Evidence |
O
|
EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
EIF3S2 |
EIF3S2, TRIP1: Eukaryotic translation initiation factor 3 subunit 2 |
1.14E4 |
Evidence |
O
|
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
1.12E4 |
Evidence |
O
|
INHBA |
INHBA: Inhibin beta A chain precursor |
ACVR2A |
ACVR2A, ACVR2: Activin receptor type-2A precursor |
9.69E3 |
Evidence |
O
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
9.49E3 |
Evidence |
O
|
HCK |
IPI00029769 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
9.29E3 |
Evidence |
O
|
SNRPF |
SNRPF, PBSCF: Small nuclear ribonucleoprotein F |
SNRPD2 |
SNRPD2, SNRPD1: Small nuclear ribonucleoprotein Sm D2 |
9.11E3 |
Evidence |
O
|
RANBP5 |
|
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
8.32E3 |
Evidence |
O
|
JUN |
JUN: Transcription factor AP-1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
7.83E3 |
Evidence |
O
|
RANBP5 |
|
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
7.47E3 |
Evidence |
O
|
ABCD3 |
ABCD3, PMP70, PXMP1: ATP-binding cassette sub-family D member 3 |
ABCD1 |
ABCD1, ALD: ATP-binding cassette sub-family D member 1 |
6.82E3 |
Evidence |
O
|
RANBP1 |
RANBP1: Ran-specific GTPase-activating protein |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
6.34E3 |
Evidence |
O
|
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
6.08E3 |
Evidence |
O
|
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
TAF12 |
TAF12, TAF15, TAF2J, TAFII20: Transcription initiation factor TFIID subunit 12 |
5.84E3 |
Evidence |
O
|